Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Honikan
- Development stage
- Unknown
- Lead developer
- USP Zdrowie
- Administration
- Oral, Topical
01
Overview
Honikan is a line of over-the-counter (OTC) products developed by USP Zdrowie, primarily indicated for the treatment of cough (both dry and productive) and sore throat. The formulations typically utilize a combination of honey and plant extracts, such as marshmallow root (*Althaea officinalis*), ribwort plantain (*Plantago lanceolata*), and *Grindelia*. These ingredients work by creating a protective film on the pharyngeal mucosa, providing a barrier against irritants, promoting hydration of mucus, and facilitating expectoration. In Poland, these products are classified as medical devices (wyrób medyczny).
- Brand names
- HonikanHonikan KaszelHonikan Gardło
Beyond the preview
Go deeper on Honikan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Honikan.